KZR
Kezar Life Sciences Inc
Price:  
6.95 
USD
Volume:  
25,988.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KZR WACC - Weighted Average Cost of Capital

The WACC of Kezar Life Sciences Inc (KZR) is 7.4%.

The Cost of Equity of Kezar Life Sciences Inc (KZR) is 7.85%.
The Cost of Debt of Kezar Life Sciences Inc (KZR) is 7.00%.

Range Selected
Cost of equity 6.90% - 8.80% 7.85%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.6% - 8.1% 7.4%
WACC

KZR WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.66 0.69
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 8.80%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.2 0.2
Cost of debt 7.00% 7.00%
After-tax WACC 6.6% 8.1%
Selected WACC 7.4%